Log in
Enquire now
Oxagen

Oxagen

A biopharmaceutical company developing small molecule drugs for asthma, chronic allergy and inflammatory conditions

OverviewStructured DataIssuesContributors

Contents

oxagen.co.uk
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Engineering
Engineering
Biotechnology
Biotechnology
Biology
Biology
Technology
Technology
Biomedical engineering
Biomedical engineering
Location
‌
Abingdon
AngelList URL
angel.co/oxagen
Pitchbook URL
pitchbook.com/profiles.../53967-61
Number of Employees (Ranges)
51 – 2000
Investors
Novartis Venture Fund
Novartis Venture Fund
Omega Funds
Omega Funds
Red Abbey Venture Partners
Red Abbey Venture Partners
International Biotechnology Trust
International Biotechnology Trust
0
Advent Venture Partners
Advent Venture Partners
Abingworth
Abingworth
OppenheimerFunds
OppenheimerFunds
...
Total Funding Amount (USD)
26,700,000
Latest Funding Round Date
November 24, 2009
Latest Funding Type
Series C
Series C
Wellfound ID
oxagen
Country
United Kingdom
United Kingdom
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Oxagen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.